Case Report: BCMA-targeting CAR T-cell therapy induces complete and durable remission in relapsed extramedullary plasmablastic multiple myeloma

Plasmablastic multiple myeloma (PBM) is an aggressive multiple myeloma (MM) form, identified by a high risk of recurrence and poor prognosis, with limited effective treatment options. Present study reports a case initially diagnosed with IgG-kappa MM with double-hit genetics. Following induction che...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Immunology
المؤلفون الرئيسيون: Lili Zhou, Paul Ning Man Cheng, Jian-qing Mi
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Frontiers Media S.A. 2025-05-01
الموضوعات:
BCMA CAR-T
extramedullary
plasmablastic multiple myeloma
Equecabtagene Autoleucel
maintenance
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1567403/full

الانترنت

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1567403/full

مواد مشابهة